Stem Cell Research (Apr 2021)

Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (Ɛ2/Ɛ3/Ɛ4) and knock-out for the study of APOE biology in health and disease

  • Benjamin Schmid,
  • Bjørn Holst,
  • Christian Clausen,
  • Lamiaa Bahnassawy,
  • Peter Reinhardt,
  • Margot H.M. Bakker,
  • Eva Díaz-Guerra,
  • Carlos Vicario,
  • Pamela V. Martino-Adami,
  • Michaela Thoenes,
  • Alfredo Ramirez,
  • Klaus Flissbach,
  • Clara Grezella,
  • Oliver Brüstle,
  • Michael Peitz,
  • Andreas Ebneth,
  • Alfredo Cabrera-Socorro

Journal volume & issue
Vol. 52
p. 102180

Abstract

Read online

APOE genotype is the strongest genetic risk factor for Alzheimer’s Disease (AD). The low degree of homology between mouse and human APOE is a concerning issue in preclinical models currently used to study the role of this gene in AD pathophysiology. A key objective of ADAPTED (Alzheimer's Disease Apolipoprotein Pathology for Treatment Elucidation and Development) project was to generate in vitro models that better recapitulate human APOE biology. We describe a new set of induced pluripotent stem cells (iPSC) lines carrying common APOE variants (Ɛ2, Ɛ3, and Ɛ3/Ɛ4) and a knock-out isogenic to the parental APOE Ɛ4/Ɛ4 line (UKBi011-A).